Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Addex Therapeutics Ltd ADR (ADXN)

Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,441
  • Shares Outstanding, K 1,232
  • Annual Sales, $ 460 K
  • Annual Income, $ 8,010 K
  • EBIT $ -3 M
  • EBITDA $ -3 M
  • 60-Month Beta 1.48
  • Price/Sales 221.76
  • Price/Cash Flow N/A
  • Price/Book 0.81

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.57 +9.34%
on 03/18/26
7.26 -16.12%
on 03/11/26
-1.08 (-15.06%)
since 03/06/26
3-Month
5.57 +9.34%
on 03/18/26
10.43 -41.61%
on 01/13/26
-1.85 (-23.30%)
since 01/07/26
52-Week
5.57 +9.34%
on 03/18/26
12.05 -49.46%
on 09/12/25
-1.07 (-14.94%)
since 04/07/25

Most Recent Stories

More News
Addex Therapeutics Reports Significant Loss Amid Financial Challenges

Addex Therapeutics Ltd (ADR) ( (ADXN) ) has released its Q2 earnings. Here is a breakdown of the information Addex Therapeutics Ltd (ADR) presented to its investors.Elevate Your Investing Strategy: Take...

ADXN : 6.09 (+0.83%)
Addex Completes $4.2 Million Equity Financing

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 26, 2022 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage...

ADXN : 6.09 (+0.83%)
Addex Shareholders Approve All Resolutions at Annual General Meeting

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 10, 2022 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company...

ADXN : 6.09 (+0.83%)
Addex Reports Q1 2022 Financial Results

CHF14.9M ($16.1M) of cash and cash equivalents at March 31, 2022Dipraglurant Phase 2 blepharospasm clinical trial on track to report data in Q2 2022Phase...

ADXN : 6.09 (+0.83%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are scheduled...

TRIQ : 0.4000 (-27.27%)
DMIFF : 0.0199 (unch)
PBLA : 0.0026 (+1,200.00%)
THBRF : 1.2101 (-3.19%)
ATGN : 0.4200 (-4.11%)
STRR : 9.69 (-0.62%)
ADXN : 6.09 (+0.83%)
MKTY : 12.66 (-1.40%)
BTX : 6.66 (-1.33%)
FLUX : 1.1350 (-2.99%)
NMTC : 0.8365 (+0.80%)
NEPH : 2.75 (-3.85%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual...

DMIFF : 0.0199 (unch)
PBLA : 0.0026 (+1,200.00%)
ATGN : 0.4200 (-4.11%)
STRR : 9.69 (-0.62%)
ADXN : 6.09 (+0.83%)
MKTY : 12.66 (-1.40%)
FLUX : 1.1350 (-2.99%)
NMTC : 0.8365 (+0.80%)
NEPH : 2.75 (-3.85%)
ACER : 0.6601 (-17.95%)
BSFC : 0.0006 (+20.00%)
DTST : 3.86 (-0.25%)

Business Summary

Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused on the development and commercialization of small molecule drugs for neurological disorders. The company's lead drug candidate includes dipraglurant, ADX71149 which are in clinical stage. Its Preclinical programs include...

See More

Key Turning Points

3rd Resistance Point 6.24
2nd Resistance Point 6.14
1st Resistance Point 6.09
Last Price 6.09
1st Support Level 5.94
2nd Support Level 5.84
3rd Support Level 5.79

See More

52-Week High 12.05
Fibonacci 61.8% 9.57
Fibonacci 50% 8.81
Fibonacci 38.2% 8.05
Last Price 6.09
52-Week Low 5.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.